Schedule 13D ownership disclosure

Rani Therapeutics Holdings, Inc.

Security class unavailable

Event date: 2023-11-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
46.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-124732
Form type
SC 13D/A
Filer
Rani Therapeutics Holdings, Inc.
CIK
CIK 1856725
Filed
Dec 08, 2023
Reporting period
Nov 24, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub